DIPHENHYDRAMINE ANTITUSSIVE/ANTIHISTAMINE MONOGRAPH DIRECTIONS FOR USE
This article was originally published in The Tan Sheet
Executive Summary
DIPHENHYDRAMINE ANTITUSSIVE/ANTIHISTAMINE MONOGRAPH DIRECTIONS FOR USE are among the issues that "need to be resolved before diphenhydramine can be used to perform both functions (antitussive and antihistamine)," FDA said in a notice published in the June 3 Federal Register. The agency is concerned, specifically, with the "amount of drug to be taken and time interval for taking the drug." The notice, a final rule amending the final monograph for OTC antitussives, allows the use of diphenhydramine citrate and diphenhydramine hydrochloride in single-ingredient antitussive products only.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning